Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of bupropion versus sertraline for depression in Parkinson's disease
IRCT20200513047429N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupropion and sertraline in major depressive disorder (MDD) and Parkinson's disease (PD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
bupropionsertraline
03
Conditions
major depressive disorder (MDD)Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20200513047429N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200513047429N1.